JAIDS Journal of Acquired Immune Deficiency Syndromes · 2003 · 23 citations · 31 references
Life SciencesImmunologyAdaptive ImmunityClinical ImmunologyMolecular VirologyAntiretroviral TherapyAntiviral TherapyEffector T Cell FunctionMaintenance TherapyCd4 Positive T Cell DifferentiationCd4 Positive T CellsCd4+ T Helper Cell ResponsesHighly Active Antiretroviral TherapyHiv Antiretroviral TherapyImmune Reconstitution After Antiretroviral TherapyPilot Study DesignTreatment Interruption Effects
Markers of maturation and activation were measured on peripheral CD4+ T cells in chronically HIV-1-infected patients in a randomized, controlled pilot study of structured treatment interruption (STI). Eight subjects underwent 2 cycles of 1 month off and 1 month on highly active antiretroviral therapy (HAART), followed by a final 3-month interruption. During STI, CD4+ T-cell percentage remained relatively stable in 4 of 8 subjects. The remaining 4 STI subjects had significant rapid decline in CD4+ T-cell percentage during STI, followed by return to pre-STI baseline while on HAART. Changes in overall CD4+ T-cell percentage corresponded with fluctuations in the CD45RA+CCR7+ naive and CD45RA-CCR7+ central memory subsets. Subjects with variable CD4+ T-cell percentages tended to have higher pre-HAART plasma HIV-1 RNA set-points and experienced higher levels of plasma HIV-1 RNA rebound during STI. These results suggest that interruptions should be avoided whenever possible in patients on HAART with high plasma HIV-1 RNA set-points.
31
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
Federica Sallusto, Danielle Lenig, Reinhold Förster et al. · Nature · 1999 · 5.8K citations
Changes in thymic function with age and during the treatment of HIV infection
Daniel C. Douek, Richard McFarland, Philip Keiser et al. · Nature · 1998 · 1.9K citations